PT Dexa Medica through the DLBS (Dexa Laboratories of Biomolecular Sciences) Bioactive Fraction production facilities - which have met the requirements of Natural Ingredients Extraction Industry (IEBA), is ready to produce active pharmaceutical ingredients from Indonesian natural resources.
OGBdexa participated in the Health Development Exhibition 2014 that was held to commemorate the 50th National Health Day at the National Monument area, November 14-16, 2014.
PT Dexa Medica brought its featured products, Inlacin and Dexanorm, to the Indonesian Diabetic Association (PERSADIA) on October 25, 2014, at the JW Marriott, Surabaya.
PT Dexa Medica will be holding walk-in interviews that will take place in Jakarta, Surabaya and Depok-West Java.
PT Dexa Medica participated in the international pharmacy exhibition, "Convention on Pharmaceutical Ingredients (CPhI) Worldwide during October 7-9, 2014 at Paris Nord Villepinte, France.
There's already a diabetes drug produced by an Indonesian company, which is Inlacin, categorized as an insulin sensitizer that was developed in the Dexa Medica laboratory.
Dexa Medica gave Dexa Award to four pharmacists from UGM, USD, UI, and UNPAD.
This participation is intended to raise awareness on healthy lifestyle.
STIMUNO Syrup and STIMUNO Forte elected as Indonesia Most Recommended Band 2014, in the "Children's System Immunity Vitamin" and "Adult's System Immunity Vitamin" categories on the Word of Mouth Marketing (WOMM) 2014.
Pada Minggu, 8 Juni 2014, Kompetisi Senam STIMUNO digelar di ajang "Clean-A-Thon" yang diadakan di kawasan Gelora Bung Karno, Senayan.
Kompetisi Senam STIMUNO "Gerak itu Sehat" digelar di Carrefour Express Dewi Sartika, Depok, pada Sabtu, 17 Mei 2014.
This seminar is one of the events in a series of "Vitafem Free Me Relaunch" activities.